| Joseph B Coates, MD | |
|
4035 Electric Rd, Suite A, Roanoke, VA 24018-8433 | |
| (540) 772-8670 | |
| (540) 772-7901 |
| Full Name | Joseph B Coates |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 4035 Electric Rd, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811108913 | NPI | - | NPPES |
| VV6737A | Other | VA | MEDICARE PTAN |
| VV6737B | Other | VA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101245898 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carilion Healthcare Corporation | 5890607253 | 408 |
| Carilion Emergency Services Inc | 7012820889 | 42 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
Using the four signs to identify the extent and type of damage to knee cartilage makes interpreting MRIs with higher degrees of accuracy easier for any radiologist, regardless of their level of expertise.
Brigham and Women's Hospital (BWH) researchers have created a vaccine that is more potent than traditional vaccines available today. The glycoconjugate vaccine prototype is 100 times more effective than traditional glycoconjugate vaccines. Their work is published in the December 2011 issue of Nature Medicine.
AMD is the leading cause of vision loss in anyone over 50 and globally in 2010 it was estimated to cost $340 billion to treat AMD. The costs are set to spiral over the next 20 years and really over burden the healthcare system unless people start to take preventative action.
› Verified 2 days ago
| Entity Name | Carilion Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447206370 PECOS PAC ID: 5890607253 Enrollment ID: O20031106000273 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
Using the four signs to identify the extent and type of damage to knee cartilage makes interpreting MRIs with higher degrees of accuracy easier for any radiologist, regardless of their level of expertise.
Brigham and Women's Hospital (BWH) researchers have created a vaccine that is more potent than traditional vaccines available today. The glycoconjugate vaccine prototype is 100 times more effective than traditional glycoconjugate vaccines. Their work is published in the December 2011 issue of Nature Medicine.
AMD is the leading cause of vision loss in anyone over 50 and globally in 2010 it was estimated to cost $340 billion to treat AMD. The costs are set to spiral over the next 20 years and really over burden the healthcare system unless people start to take preventative action.
› Verified 2 days ago
| Entity Name | Carilion Emergency Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255602694 PECOS PAC ID: 7012820889 Enrollment ID: O20031107000339 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
Using the four signs to identify the extent and type of damage to knee cartilage makes interpreting MRIs with higher degrees of accuracy easier for any radiologist, regardless of their level of expertise.
Brigham and Women's Hospital (BWH) researchers have created a vaccine that is more potent than traditional vaccines available today. The glycoconjugate vaccine prototype is 100 times more effective than traditional glycoconjugate vaccines. Their work is published in the December 2011 issue of Nature Medicine.
AMD is the leading cause of vision loss in anyone over 50 and globally in 2010 it was estimated to cost $340 billion to treat AMD. The costs are set to spiral over the next 20 years and really over burden the healthcare system unless people start to take preventative action.
› Verified 2 days ago
| Entity Name | Carilion Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730123472 PECOS PAC ID: 9830096585 Enrollment ID: O20040107000472 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
Using the four signs to identify the extent and type of damage to knee cartilage makes interpreting MRIs with higher degrees of accuracy easier for any radiologist, regardless of their level of expertise.
Brigham and Women's Hospital (BWH) researchers have created a vaccine that is more potent than traditional vaccines available today. The glycoconjugate vaccine prototype is 100 times more effective than traditional glycoconjugate vaccines. Their work is published in the December 2011 issue of Nature Medicine.
AMD is the leading cause of vision loss in anyone over 50 and globally in 2010 it was estimated to cost $340 billion to treat AMD. The costs are set to spiral over the next 20 years and really over burden the healthcare system unless people start to take preventative action.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph B Coates, MD 4035 Electric Rd, Suite A, Roanoke, VA 24018-8433 Ph: (540) 772-8670 | Joseph B Coates, MD 4035 Electric Rd, Suite A, Roanoke, VA 24018-8433 Ph: (540) 772-8670 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
Using the four signs to identify the extent and type of damage to knee cartilage makes interpreting MRIs with higher degrees of accuracy easier for any radiologist, regardless of their level of expertise.
Brigham and Women's Hospital (BWH) researchers have created a vaccine that is more potent than traditional vaccines available today. The glycoconjugate vaccine prototype is 100 times more effective than traditional glycoconjugate vaccines. Their work is published in the December 2011 issue of Nature Medicine.
AMD is the leading cause of vision loss in anyone over 50 and globally in 2010 it was estimated to cost $340 billion to treat AMD. The costs are set to spiral over the next 20 years and really over burden the healthcare system unless people start to take preventative action.
› Verified 2 days ago
Lindsay R Wilson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1314 Peters Creek Rd Nw, Roanoke, VA 24017 Phone: 540-562-5703 Fax: 540-562-4278 | |
Vitaly Kishinyovsky, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2145 Mount Pleasant Blvd Se, Roanoke, VA 24014 Phone: 540-427-9200 | |
Sujina Pradhan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7000 | |
Dr. Uzma M Ali, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2133 Pelham Dr, Roanoke, VA 24018 Phone: 540-283-9039 Fax: 540-324-4164 | |
Erin K. Howes, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3707 Brambleton Ave Ste 2, Roanoke, VA 24018 Phone: 540-725-7800 Fax: 540-989-6752 | |
Christy Arthur, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3707 Brambleton Ave, Roanoke, VA 24018 Phone: 540-725-7800 | |
Todd Palmerton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6415 Peters Creek Rd, Roanoke, VA 24019 Phone: 540-265-5500 |